The effects of gabapentin in the rat hippocampus are mimicked by two structural analogs, but not by nimodipine

Epilepsy Research

Volumn 41, Issue 2, 2000, Pages 155-162

  Stringer, Janet L ^a   Taylor, Charles P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Dentate gyrus; Diazepam; Gabapentin; Inhibition; Nimodipine; Pregabalin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID DERIVATIVE; ANXIOLYTIC AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIAZEPAM; GABAPENTIN; GABAPENTIN DERIVATIVE; NIMODIPINE; PD 167345; PREGABALIN; UNCLASSIFIED DRUG; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DENTATE GYRUS; DISEASE DURATION; DOSE RESPONSE; DRUG MECHANISM; EPILEPSY; EPILEPTIC DISCHARGE; HIPPOCAMPUS; MALE; NERVE CELL INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DENTATE GYRUS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GAMMA-AMINOBUTYRIC ACID; MALE; NEURAL INHIBITION; NIMODIPINE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SEIZURES;

EID: 0033870712     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00134-0     Document Type: Article

References (27)

1. Abou-Khalil B.W., Vazquez B.R., Beydoun A.A., Elger C.E., Biton V., Krauss G.L., Smith T.M., Greiner M.J., Knapp L.E., Bockbrader H.N., Garofalo E.E. Pregabalin in-patient monotherapy trial - study results and impact of seizure frequency on efficacy evaluations. Epilepsia. 40(Suppl. 7):1999;109.
2. Aicardi G., Schwartzkroin P.A. Suppression of epileptiform burst discharges in CA3 neurons of rat hippocampal slices by the organic calcium channel blocker, verapamil. Exp. Brain Res. 81:1990;288-296.
3. Bialer M., Johannessen S.I., Kupferburg H.J., Levy R.H., Loiseau P., Perucca E. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res. 34:1999;1-41.
4. Bryans J.S., Davies N., Gee N.S., Dissanayake V.U., Ratcliffe G.S., Horwell D.C., Kneen C.O., Morrell A.I., Oles R.J., O'Toole J.C., Perkins G.M., Singh L., Suman-Chauhan N., O'Neill J.A. Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents. J. Med. Chem. 41:1998;1838-1845.
5. Chakrabarti A., Saini H.L., Garg S.K. Dose-finding study with nimodipine: a selective central nervous system calcium channel blocker on aminophylline induced seizure models in rats. Brain Res. Bull. 15:1998;495-499.
6. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271:1996;768-776.
7. Higashima M., Kinoshita H., Koshino Y. Contribution of T-type calcium channels to afterdischarge generation in rat hippocampal slices. Brain Res. 781:1998;129-136.
8. Honmou O., Kocsis J.D., Richerson G.B. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res. 20:1995;193-202.
9. Honmou O., Oyelese A.A., Kocsis D. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res. 692:1995;273-277.
10. Kapur J., Stringer J.L., Lothman E.W. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition. J. Neurophysiol. 61:1989;417-426.
11. Petroff O.A., Rothman D.L., Behar K.L., Lamoureux D., Mattson R.H. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39:1996;95-99.
12. Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneimittelforschung (Drug Res.). 44:1994;261-266.
13. Schumacher T.B., Beck H., Steinhauser C., Schramm J., Elger C.E. Effects of phenytoin, carbamazepine and gabapentin on calcium currents in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia. 39:1998;355-363.
14. Shorvon S.D. Gabapentin. Shorvon S., Dreifuss F., Fish D., Thomas D. The Treatment of Epilepsy. 1996;429-437 Blackwell Science, Oxford, UK.
15. Stefani A., Spandoni F., Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 37:1998;83-91.
16. Straub H., Kohling R., Speckmann E.J. Picrotoxin-induced epileptic activity in hippocampal and neocortical slices (guinea pig): suppression by organic calcium channel blockers. Brain Res. 658:1994;119-126.
17. B receptor activation. Epilepsy Res. 33:1999;169-176.
18. Stringer J.L., Lothman E.W. Repetitive seizures cause an increase in paired-pulse inhibition in the dentate gyrus. Neurosci. Lett. 105:1989;91-95.
19. Stringer J.L., Lothman E.W. Maximal dentate activation: characteristics and alterations after repeated seizures. J. Neurophysiol. 62:1989;136-143.
20. Stringer J.L., Lothman E.W. Maximal dentate activation: a tool to screen compounds for activity against limbic seizures. Epilepsy Res. 5:1990;169-176.
21. Stringer J.L., Lothman E.W. Use of maximal dentate activation to study the effect of drugs on kindling and kindled responses. Epilepsy Res. 6:1990;180-186.
22. Stringer J.L., Lothman E.W. Reverberatory seizure discharges in hippocampal-parahippocampal circuits. Neurology. 116:1992;198-203.
23. Taylor C.P. Gabapentin: mechanism of action. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. fourth ed. 1995;829-842 Raven Press, New York.
24. Taylor C.P. Mechanisms of new antiepileptic drugs. Delgado-Escueta A.V., Wilson W.A., Olson R.W., Porter R.J. third ed. Jasper's Basic Mechanisms of the Epilepsies: Advances in Neurology. 79:1999;1011-1032 Lippincott Williams and Wilkins, Philadelphia.
25. Taylor C.P., Vartanian M.G., Yuen P.W., Bigge C., Suman-Chauhan N., Hill D.R. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 14:1993;11-15.
26. Taylor C.P., Gee N.S., Su T.-Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
27. Xiong Z.-Q., Stringer J.L. Effects of felbamate, gabapentin and lamotrigine on seizure parameters and excitability in the rat hippocampus. Epilepsy Res. 27:1997;187-194.